Landscape Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-106,884
| Closed | -$791K | – | 750 |
|
|
2024
Q4 | $791K | Buy |
106,884
+41,359
| +63% | +$306K | 0.08% | 309 |
|
|
2024
Q3 | $615K | Buy |
+65,525
| New | +$615K | 0.06% | 366 |
|
|
2023
Q1 | – | Sell |
-16,658
| Closed | -$106K | – | 713 |
|
|
2022
Q4 | $106K | Buy |
+16,658
| New | +$106K | 0.02% | 719 |
|
|
2019
Q1 | – | Sell |
-32,093
| Closed | -$284K | – | 759 |
|
|
2018
Q4 | $284K | Hold |
32,093
| – | – | 0.02% | 663 |
|
|
2018
Q3 | $361K | Hold |
32,093
| – | – | 0.03% | 502 |
|
|
2018
Q2 | $411K | Hold |
32,093
| – | – | 0.03% | 325 |
|
|
2018
Q1 | $542K | Hold |
32,093
| – | – | 0.04% | 307 |
|
|
2017
Q4 | $257K | Hold |
32,093
| – | – | 0.02% | 512 |
|
|
2017
Q3 | $249K | Hold |
32,093
| – | – | 0.03% | 427 |
|
|
2017
Q2 | $236K | Hold |
32,093
| – | – | 0.03% | 268 |
|
|
2017
Q1 | $239K | Buy |
32,093
+12,831
| +67% | +$95.6K | 0.02% | 420 |
|
|
2016
Q4 | $134K | Hold |
19,262
| – | – | 0.02% | 518 |
|
|
2016
Q3 | $159K | Sell |
19,262
-110,934
| -85% | -$916K | 0.02% | 393 |
|
|
2016
Q2 | $1.06M | Sell |
130,196
-7,387
| -5% | -$59.9K | 0.14% | 176 |
|
|
2016
Q1 | $699K | Buy |
137,583
+45,452
| +49% | +$231K | 0.08% | 334 |
|
|
2015
Q4 | $711K | Buy |
92,131
+23,992
| +35% | +$185K | 0.09% | 300 |
|
|
2015
Q3 | $392K | Buy |
68,139
+26,039
| +62% | +$150K | 0.05% | 395 |
|
|
2015
Q2 | $386K | Buy |
42,100
+2,500
| +6% | +$22.9K | 0.07% | 438 |
|
|
2015
Q1 | $480K | Buy |
+39,600
| New | +$480K | 0.13% | 225 |
|